Interferon treatment for chronic hepatitis C in haemodialysis patients: Suggestions based on small series. J Gastroenterol Hepatol 1995; 10: 616-26.Okuda K, Hayashi H, Yokozeki K, Kondo T, Kashima T, Irie Y: Interferon treatment for chronic hepatitis C in haemodialysis patients: Suggestions based...
Hagan LM, Yang Z, Ehteshami M, Schinazi RF (2013) All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses. J Viral Hepat 20: 847-857.All‐oral, interferon‐free treatment for chronic hepatitis C : cost‐effectiveness analyses[J] . L. M. Hagan,Z. Yang,...
Presents two cases of celiac disease that developed during interferon and ribavirin treatment for chronic hepatitis C. Medical history of the patients; Mechanism of action of ribavirin; Advantage of screening for antiendomysium antibodies.American Journal of Gastroenterology...
Background Most research on the psychiatric symptoms of peginterferon/ribavirin for the treatment of hepatitis C comes from VA centres and clinical trials with rigid entry criteria that often excluded patients with markers of mental health and substance use disturbance (MH/SUD). The findings from the...
摘要: To the Editor: Dr Wong and colleagues1examined the cost-effectiveness of management strategies for patientswith chronic hepatitis C, and the authors concluded that a 12-weekinitial empirical trial of interferon alfa-2b is a关键词:biopsy cost benefit analysis cost effectiveness hepatitis c ...
Interferontreatment for chronic hepatitis C reduces the incidence of hepatocellular carcinoma ( HCC ) in sustained responders. 干扰素治疗慢性丙型肝炎发生持续应答的患者肝细胞癌 ( HCC ) 的发生率显著降低. 期刊摘选 Lamivudine andinterferoncombination with or without lamivudine priming showed encouraging results...
C. LIDDLELiddle C: Interferon treatment of hepatitis C—Is it a virological cure? J Gastroenterol Hepatol 8:209–211, 1993Liddle C,et al.Interferon treatment of hepatitis C: Is it virological cure.Journal of Gastroenterology and Hepatology. 1993...
(HealthDay)—For untreated patients with hepatitis C virus (HCV), treatment with an oral nucleotide inhibitor of HCV polymerase, sofosbuvir, plus ribavirin seems effective for genotypes 1, 2, and 3; and the HCV NS3 protease inhibitor ABT-450, combined wi
Background The immunosuppressive potential of anti-tumor necrosis factor (TNF) in exacerbating chronic hepatitis C virus (HCV) infection has been a major c... Teruhito,AWAKAWA,Sae,... - 《Nippon Shokakibyo Gakkai Zasshi》 被引量: 9发表: 2003年 [Recombinant alfa-2 interferon treatment of a...
TRANSDERMAL NICOTINE TREATMENT FOR ULCERATIVE-COLITIS-A CONTROLLED TRIAL significant Aiming to evaluate the primary response and the frequency of relapse after short-term (6 months) or long-term (12 months) alfa-interferon (IFN) treatment in patients with HCV-related chronic hepatitis. We enrolled ...